Ashley Cordova
About Ashley Cordova
Ashley Cordova is the Chief Financial Officer at Novocure and a Member of the Board of Directors at Therabody, with extensive experience in financial management across the pharmaceutical, animal health, and medical technology industries.
Current Roles and Responsibilities
Ashley Cordova currently serves as the Chief Financial Officer at Novocure where she handles the financial operations of the company. She is also a Member of the Board of Directors at Therabody, contributing to strategic decisions and oversight since January 2022.
Professional Journey at Novocure
At Novocure, Ashley Cordova has held multiple roles, starting as Director of Global Treasury in 2014 and progressing through positions such as Senior Director, Investor Relations and Global Treasury, Vice President, Finance and Investor Relations, and Senior Vice President, Finance and Investor Relations. She has been instrumental in financial management and strategic planning during her tenure.
Previous Experience at Pfizer and Zoetis
Prior to Novocure, Ashley Cordova worked at Pfizer where she held various roles including Strategic Alternatives Director, Finance Director, and Audit Supervisor. At Zoetis, she was the Director of the Treasury Center in Belgium, managing financial operations and contributing to the growth phases of the company.
Educational Background
Ashley Cordova has an IMBA in Corporate Finance and Accounting from the University of South Carolina Darla Moore School of Business. She also holds a Bachelor of Arts in Business and Music from Furman University. Her education provided a strong foundation in finance and accounting.
Industry Expertise
Ashley Cordova's extensive experience spans the pharmaceuticals, animal health, and medical technology industries. Her skill set is particularly suited for multinational life sciences or technology companies that are rapidly growing or undergoing market transformation. She has significant expertise in financial management and strategic financial planning.